NatWest Group plc - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 158 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2015. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
NatWest Group plc ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2015$550,000
-43.6%
19,316
-28.9%
0.01%0.0%
Q2 2015$976,000
-13.1%
27,172
+40.7%
0.01%
-20.0%
Q1 2015$1,123,000
+27.3%
19,316
-7.7%
0.02%
+114.3%
Q4 2014$882,00020,9310.01%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q4 2015
NameSharesValueWeighting ↓
Orbimed Advisors 5,406,844$52,014,0000.66%
ETF MANAGERS GROUP, LLC 282,268$3,255,0000.24%
Mirae Asset Global Investments Co., Ltd. 1,470,996$14,151,0000.19%
Financial Gravity Companies, Inc. 4,467$42,0000.05%
GSA CAPITAL PARTNERS LLP 67,200$646,0000.04%
TCI Wealth Advisors, Inc. 7,766$75,0000.03%
Freedom Investment Management, Inc. 64,741$623,0000.03%
GAM Holding AG 83,940$808,0000.02%
SFMG, LLC 11,994$115,0000.02%
SHELL ASSET MANAGEMENT CO 95,127$915,0000.02%
View complete list of INSYS THERAPEUTICS INC NEW shareholders